TrialClinical pharmacology in drug development2022

Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF-07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS-CoV-2, in Healthy Adult Participants.

Tong Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.